帕金森病中失调的微RNA:致病机制和潜在的生物标志物
Yasemin Ünal1, Dilek Akbaş2, Çilem Özdemir3
1Department of Neurology, Faculty of Medicine, Bandırma Onyedi Eylül University, 10200 Balıkesir, Turkey.
International journal of molecular sciences
|January 28, 2026
概括
循环中的microRNAs (miRNAs) 在帕金森病 (PD) 患者的水平发生变化. 特定的miRNAs,miR-15a-5p,miR-139-5p和miR-34a-3p,可以作为PD诊断和预后的潜在非侵入性生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物化学 生化学
背景情况:
- 帕金森病 (PD) 涉及神经退行和α-synuclein聚合.
- 循环中的微RNAs (miRNAs) 是PD的潜在生物标志物.
研究的目的:
- 在PD患者和对照患者中研究四种候选miRNA的表达水平.
- 确定这些miRNAs影响的潜在PD相关分子通路.
主要方法:
- 在47名PD患者和45名对照中使用qPCR对miR-15a-5p,miR-16-5p,miR-139-5p和miR-34a-3p的量化血水平.
- 进行了目标基因预测和功能丰富分析.
主要成果:
- 在PD患者中观察到miR-15a-5p的上调和miR-139-5p和miR-34a-3p的下调.
- miR-16-5p没有显著差异.
- 丰富的途径包括蛋白质无处不在,代谢,mTOR,PI3K-Akt,MAPK和Hippo信号传递.
结论:
- 失调的miRNAs为PD病理生理学提供了洞察力.
- 这些miRNA显示出作为PD可访问,非侵入性生物标志物的潜力.
- 需要进一步的研究来验证它们的诊断和预后价值.
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...


